Related Experiment Video
Updated: Jul 8, 2026

06:19
Constructing and Visualizing Models using Mime-based Machine-learning Framework
Published on: July 22, 2025
Multimodal Feature Prototype Learning for Interpretable and Discriminative Cancer Survival Prediction
IEEE Journal of Biomedical and Health Informatics
|July 6, 2026
Summary
This study introduces FeatProto, a novel multimodal framework for cancer survival prediction. It improves accuracy and interpretability by integrating whole slide images and genomic data using advanced prototype learning.
Area of Science:
- Computational pathology
- Bioinformatics
- Machine learning for healthcare
Background:
- Current survival analysis models lack interpretability, limiting clinical utility.
- Existing prototype learning methods in pathology neglect tumor context and genomic data integration.
- Need for interpretable and accurate multimodal approaches in cancer prognosis.
Purpose of the Study:
- To develop an innovative prototype-based multimodal framework, FeatProto, for enhanced cancer survival prediction.
- To address limitations of traditional prototype learning by integrating global and local image features with genomic data.
- To provide traceable and interpretable decision-making in cancer prognosis.
Main Methods:
- Developed FeatProto, a unified feature prototype space integrating whole slide image (WSI) features and genomic profiles.
- Introduced a robust phenotype representation merging critical patches with global context, harmonized with genomic data.
- Implemented an Exponential Prototype Update Strategy (EMA ProtoUp) for stable cross-modal associations and adaptive prototype learning.
- Utilized a hierarchical prototype matching scheme for global centrality, local typicality, and cohort trend inference.
Main Results:
- FeatProto demonstrated superior accuracy and interpretability compared to leading unimodal and multimodal survival prediction methods.
- The framework successfully integrated diverse data modalities, enhancing predictive performance.
- Evaluations on four public cancer datasets validated the method's effectiveness.
Conclusions:
- FeatProto offers a significant advancement in prototype learning for cancer survival analysis.
- The multimodal approach provides a new perspective for interpretable and accurate clinical decision support.
- This framework holds promise for critical medical applications requiring robust prognostic tools.